Wecare at The Green Home

In the surveyor’s words

From the most serious findings on record at Wecare at The Green Home, in the surveyor’s own words.

• No harm, potential for more than minimal, widespreadF880Jan 12, 2024

  Based on observation and staff interview, it was determined that the facility failed to maintain linens in a sanitary manner in the facility's main linen supply storage area. Findings include: In an interview with Employee 6, Assistant Director of Nursing, on January 12, 2024, at 11:30 AM, Employee 6 indicated the facility does not complete any laundering of linens or resident items in the facility and items were sent out of the facility to be laundered. In a concurrent observation of the area, clean linens and laundry are returned to the facility that Employee 6 revealed to be an area through a door in the back service hallway of the facility. Upon entering the door, a storage area behind a metal cage was observed on the left, which contained mattresses and multiple other items. […]

• No harm, potential for more than minimal, patternF568Dec 13, 2024

  Based on a review of resident personal fund accounting, clinical record review, and resident, family, and staff interview, it was determined that the facility failed to provide a personal fund quarterly statement for two of two residents reviewed for personal funds concerns (Residents 19 and 40). Findings include: Interview with Resident 19 on December 10, 2024, at 1:41 PM revealed that she had an idea regarding how much money she had in her personal funds account; however, she does not receive a written statement at least quarterly with her personal funds accounting. […]

• No harm, potential for more than minimal, patternF688Dec 13, 2024

  Based on clinical record review and resident and staff interview, it was determined that the facility failed to provide physician ordered services to maintain a resident's mobility for one of four residents reviewed (Resident 71), maintain a resident's range of motion program for one of four residents reviewed (Resident 14), and failed to provide services to prevent a decline in a resident's range of motion for one of four resident's reviewed (Resident 11). Findings include: Observation and interview with Resident 71 on December 10, 2024, at 1:09 PM revealed she was lying on her bed. Resident 71 stated she was planning on returning home and had finished therapy, but thought she was going to do more therapy to keep her strength to return home, such as walking. […]

• No harm, potential for more than minimal, patternF758Dec 13, 2024

  Based on clinical record review and staff interview, it was determined that the facility failed to ensure a resident's medication regime was free from potentially unnecessary medications for one of two residents reviewed for behaviors(Resident 12). Findings include: Clinical record review for Resident 12 revealed the following current physician orders: Ativan 0.5 milligram (mg) PO (by mouth) BID (twice daily), initially ordered September 26, 2023 Ativan 2 mg PO q HS (hour of sleep), initially ordered December 16, 2023 Ativan 1 mg PO PRN (as needed) q 4 hours (every four hours) for restlessness/anxiety for 120 days, initially ordered on October 29, 2024 Antianxiety Drug Monitoring TID (three times daily) for anxiety/insomnia Resident 12 had the potential to receive 9 mg of Ativan in a… […]

• No harm, potential for more than minimal, patternF842Dec 13, 2024

  Based on clinical record review and staff interview, it was determined that the facility failed to ensure complete and accurate clinical documentation for one of 20 residents reviewed (Resident 12). Findings include: Clinical record review for Resident 12 revealed the following current physician orders: Ativan 0.5 milligram (mg) PO (by mouth) BID (twice daily at 8:30 and 5:00 PM), initially ordered September 26, 2023 Ativan 2 mg PO q HS (hour of sleep, 8:00 PM), initially ordered September 26, 2023 Ativan 1 mg PO PRN (as needed) q 4 hours (every four hours) for restlessness/anxiety for 120 days, initially ordered on October 29, 2024 Morphine 100 mg/5 ml (20 mg/ml) 5 mg/0.25 ml PO q 2 hours for moderated pain 4-7, initially ordered on March 30, 2023 Review of Resident 12's October,… […]